Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

p62/Sequestosome-1: Mapping Sites of Protein-Handling Stress in Canine Cutaneous Mast Cell Tumors.

Rich T, Dean RT, Lamm CG, Ramiro-Ibañez F, Stevenson ML, Patterson-Kane JC.

Vet Pathol. 2014 Aug 26. pii: 0300985814548489. [Epub ahead of print]

PMID:
25161207
[PubMed - as supplied by publisher]
2.

CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.

Meyer A, Gruber AD, Klopfleisch R.

Vet Pathol. 2012 Nov;49(6):988-97. doi: 10.1177/0300985812439215. Epub 2012 Mar 23.

PMID:
22446323
[PubMed - in process]
Free Article
3.

Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.

Kitamura H, Torigoe T, Asanuma H, Hisasue SI, Suzuki K, Tsukamoto T, Satoh M, Sato N.

Histopathology. 2006 Jan;48(2):157-61.

PMID:
16405664
[PubMed - indexed for MEDLINE]
4.

Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.

Preziosi R, Morini M, Sarli G.

J Vet Diagn Invest. 2004 Nov;16(6):554-61.

PMID:
15586571
[PubMed - indexed for MEDLINE]
Free Article
5.

Histologic Grading of Canine Mast Cell Tumor: Is 2 Better Than 3?

Sabattini S, Scarpa F, Berlato D, Bettini G.

Vet Pathol. 2014 Feb 10. [Epub ahead of print]

PMID:
24513799
[PubMed - as supplied by publisher]
6.

Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.

Ginn PE, Fox LE, Brower JC, Gaskin A, Kurzman ID, Kubilis PS.

Vet Pathol. 2000 Jan;37(1):33-9.

PMID:
10643978
[PubMed - indexed for MEDLINE]
Free Article
7.

Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.

Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA.

Cancer Biol Ther. 2013 Feb;14(2):100-7. doi: 10.4161/cbt.22954. Epub 2012 Nov 28.

PMID:
23192274
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.

Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.

Vet Pathol. 2004 Jul;41(4):371-7. Erratum in: Vet Pathol. 2004 Sep;41(5):543.

PMID:
15232137
[PubMed - indexed for MEDLINE]
Free Article
9.

Dynamic subcellular localization of the mono-ADP-ribosyltransferase ARTD10 and interaction with the ubiquitin receptor p62.

Kleine H, Herrmann A, Lamark T, Forst AH, Verheugd P, Lüscher-Firzlaff J, Lippok B, Feijs KL, Herzog N, Kremmer E, Johansen T, Müller-Newen G, Lüscher B.

Cell Commun Signal. 2012 Sep 20;10(1):28. doi: 10.1186/1478-811X-10-28.

PMID:
22992334
[PubMed]
Free PMC Article
10.

New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.

Rea SL, Walsh JP, Layfield R, Ratajczak T, Xu J.

Endocr Rev. 2013 Aug;34(4):501-24. doi: 10.1210/er.2012-1034. Epub 2013 Apr 23. Review.

PMID:
23612225
[PubMed - indexed for MEDLINE]
11.

E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors.

Mackowiak II, Gentile LB, Chaible LM, Nagamine MK, Guerra JM, Mota EF, Matera JM, Mennecier G, Sanches DS, Dagli ML.

Vet J. 2012 Dec;194(3):405-11. doi: 10.1016/j.tvjl.2012.05.015. Epub 2012 Jul 4.

PMID:
22766308
[PubMed - indexed for MEDLINE]
12.

Glucocorticoid sensitivity depends on expression levels of glucocorticoid receptors in canine neoplastic mast cells.

Matsuda A, Tanaka A, Amagai Y, Ohmori K, Nishikawa S, Xia Y, Karasawa K, Okamoto N, Oida K, Jang H, Matsuda H.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):321-8. doi: 10.1016/j.vetimm.2011.08.013. Epub 2011 Aug 26.

PMID:
21908058
[PubMed - indexed for MEDLINE]
13.

Regulation of C1-Ten protein tyrosine phosphatase by p62/SQSTM1-mediated sequestration and degradation.

Koh A, Park D, Jeong H, Lee J, Lee MN, Suh PG, Ryu SH.

Cell Signal. 2014 Nov;26(11):2470-80. doi: 10.1016/j.cellsig.2014.07.033. Epub 2014 Aug 4.

PMID:
25101860
[PubMed - in process]
14.

Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.

Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F.

Vet Pathol. 2013 Jan;50(1):110-21. doi: 10.1177/0300985812447829. Epub 2012 Jun 6.

PMID:
22673539
[PubMed - in process]
Free Article
15.

CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.

Gil da Costa RM, Matos E, Rema A, Lopes C, Pires MA, Gärtner F.

BMC Vet Res. 2007 Aug 21;3:19.

PMID:
17711582
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

p62 at the interface of autophagy, oxidative stress signaling, and cancer.

Nezis IP, Stenmark H.

Antioxid Redox Signal. 2012 Sep 1;17(5):786-93. doi: 10.1089/ars.2011.4394. Epub 2012 Jan 11. Review.

PMID:
22074114
[PubMed - indexed for MEDLINE]
17.

Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.

Schlieben P, Meyer A, Weise C, Bondzio A, Einspanier R, Gruber AD, Klopfleisch R.

Vet J. 2012 Nov;194(2):210-4. doi: 10.1016/j.tvjl.2012.04.002. Epub 2012 May 10.

PMID:
22578690
[PubMed - indexed for MEDLINE]
18.

Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.

Pankiv S, Lamark T, Bruun JA, Øvervatn A, Bjørkøy G, Johansen T.

J Biol Chem. 2010 Feb 19;285(8):5941-53. doi: 10.1074/jbc.M109.039925. Epub 2009 Dec 15.

PMID:
20018885
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inverse correlation between microtubule-associated protein 1A/1B-light chain 3 and p62/sequestosome-1 expression in the progression of cutaneous squamous cell carcinoma.

Yoshihara N, Takagi A, Ueno T, Ikeda S.

J Dermatol. 2014 Apr;41(4):311-5. doi: 10.1111/1346-8138.12439.

PMID:
24690104
[PubMed - in process]
20.

c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.

Giantin M, Vascellari M, Morello EM, Capello K, Vercelli A, Granato A, Lopparelli RM, Nassuato C, Carminato A, Martano M, Mutinelli F, Dacasto M.

J Vet Diagn Invest. 2012 Jan;24(1):116-26. doi: 10.1177/1040638711425945. Epub 2011 Dec 6.

PMID:
22362941
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk